Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: A meta-analysis

Europace

Volumn 16, Issue 3, 2014, Pages 347-353

  Guerra, Federico ^a   Shkoza, Matilda ^a   Scappini, Lorena ^a   Flori, Marco ^a   Capucci, Alessandro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Electrical storm; Implantable cardioverter defibrillator; Meta analysis; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART FAILURE; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; ELECTRICAL STORM; HEART ARRHYTHMIA; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION;

ELECTRICAL STORM; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; META-ANALYSIS; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA;

COMORBIDITY; DEATH, SUDDEN, CARDIAC; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MEDLINE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 84895761199     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut304     Document Type: Article

References (28)

1. Israel CW, Barold SS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol 2007;12:375-82.
2. Huang DT, Traub D. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review. Prog Cardiovasc Dis 2008;51:229-36.
3. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
4. Bänsch D, Böcker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathyand implantable cardioverter defibrillators. J Am Coll Cardiol 2000;36:566-73.
5. Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gérard F et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006;27:700-7.
6. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter- defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998;32:1909-15.
7. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M et al. Electrical storm presages non sudden death: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Circulation 2001;103:2066-71.
8. Fries R, Heisel A, Huwer H, Nikoloudakis N, Jung J, Schäfers HJ et al. Incidence and clinical significance of short-term recurrent ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillator. Int J Cardiol 1997;59:281-4.
9. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J et al. Electrical storm is an independent predictor of adverse long-termoutcome in the era of implantable defibrillator therapy. Europace 2005;7:184-92.
10. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2000;2:263-69.
11. Hohnloser SH, Al-Khalidi HR, Pratt CM, Brum JM, Tatla DS, Tchou P et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 2006;27:3027-32.
12. Nordbeck P, Seidl B, Fey B, Bauer WR, Ritter O. Effect of cardiac resynchronization therapy on the incidence of electrical storm. Int J Cardiol 2010;143:330-6.
13. Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML et al.; MADIT-II Research Group. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007;4:1395-402.
14. Stuber T, Eigenmann C, Delacrétaz E. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients. Pacing Clin Electrophysiol 2005; 28:702-7.
15. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004;15:1265-70.
16. Arya A, Haghjoo M, Reza Dehghani MR, Fazelifar AF, Nikoo MH, Ataollah Bagherzadeh A et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol 2006;97:389-92.
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Third Symposium on Systematic Reviews: Beyond the Basics 2000.
18. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
19. Biondi-Zoccai GG, Abbate A, Agostoni P, Testa L, Burzotta F, Lotrionte M et al. Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression. Am Heart J 2005;149:504-11.
20. Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses. J Am Coll Cardiol 1999;33:24-32.
21. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7:353-60.
22. Runsiö M, Bergfeldt L, Brodin LA, Ribeiro A, Samuelsson S, Rosenqvist M. Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography. Eur Heart J 1997;18: 124-31.
23. Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short-and long-term outcomes in a prospective singlecenter study. Circulation 2008;117:462-9.
24. Deneke T, Shin DI, Lawo T, Bösche L, Balta O, Anders H et al. Catheter ablation of electrical storm in a collaborative hospital network. Am J Cardiol 2011;108: 233-9.
25. Friedman DJ, Altman RK, Orencole M, Picard MH, Ruskin JN, Singh JP et al. Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2012;5:762-72.
26. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012;33:1787-847.
27. Lau J, Ioannidis JPA, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998;351:123-7.
28. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367:2275-83.